Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,000
Closed -$95K 7078
2019
Q1
$95K Sell
1,000
-10,000
-91% -$1.25M ﹤0.01% 5397
2018
Q4
$1.37M Buy
+11,000
New +$1.81M ﹤0.01% 2797

Other funds holding INGN

Barclays's INGN Position: Q2 2026 in Review

Barclays reduced its Inogen (INGN) stake by 1.1% in Q2 2026, selling an estimated $3.18K and leaving 42,607 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #3536.

Barclays first reported a position in INGN in Q1 2014 and has held it in 50 quarters since. The position peaked at $3.79M in Q4 2015. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Barclays held 42,607 shares of Inogen worth $275K as of Q2 2026.
  • Barclays sold 480 Inogen shares in Q2 2026, an estimated $3.18K.
  • Inogen made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3536 holding.
  • Barclays first reported a position in Inogen in Q1 2014 and has held it in 50 quarters since.
  • Barclays's Inogen position peaked at $3.79M in Q4 2015.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.